Bupropion in the Treatment of Methamphetamine Dependence
Status:
Completed
Trial end date:
2011-05-20
Target enrollment:
Participant gender:
Summary
Methamphetamine dependence is a significant drug use disorder in the Midwest. While a number
of psychosocial and pharmacological treatments have been studied, no specific treatments for
methamphetamine have been identified. This study is a collaborative pre-clinical and clinical
partnership examining bupropion in the treatment of methamphetamine dependence.